RxUtility announced the launch of Mimi™, the healthcare industry’s most comprehensive AI companion for medication cost options, now free during beta.
A woman attempted to hide under the covers of a child’s bed when police found and arrested her for possessing a whopping ...
As AstraZeneca braces for the impact of the U.S. “most favored nation” drug pricing policy, CEO Pascal Soriot suggests that a ...
Pharmalittle: We’re reading about warnings over Trump’s MFN plan, Purdue Pharma sentencing, and more
The Novartis CEO warned that Trump's drug pricing policy poses a “very difficult situation” and the reality will soon catch ...
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) is one of the best drug stocks to buy according to analysts. ANI Pharmaceuticals, Inc ...
At Asembia AXS26, Clarivate’s Dee Chaudhary outlined how U.S. drug pricing policy is rapidly shifting, driving more ...
Opinion
5don MSNOpinion
Opinion: Senate Bill 1094 is a dose of common sense for California drug prices
New legislation would authorize pharmacists to substitute a biosimilar when filling a prescription, just like a generic, provided your doctor agrees.
DMF No. 43568 is now active and available for reference in global IND and NDA submissions CHENGDU, China, April 28, 2026 ...
The FDA has released the findings of a comprehensive test of infant formula in the U.S. CR's experts say some of the results ...
Regulatory approval is a major milestone in the drug development process, but it is not the final chapter in the journey.
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) is one of the best drug stocks to buy according to analysts. On April 7, RBC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results